China's pharma manufacturing gains momentum

The total value of external licensing deals for innovative pharmaceuticals has risen to $110 billion, accompanied by increased interest from global companies in developing new products and health innovations. Data indicates that this accumulation reflects ongoing growth in the innovative pharmaceutical market, with expectations of further increases in the coming years due to recent technological and research trends.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل